For a moment, it felt like justice had been served. Then reality sank in.
Earlier today, the Supreme Court ruled in favor of Bayer, making it harder for thousands of cancer patients to sue over exposure to glyphosate, the active ingredient in Monsanto's Roundup. The decision? Federal law preempts state failure-to-warn claims when the EPA has already approved a product's label. Translation: If the feds say it's okay, states can't demand extra warnings.
Legally, it's clean. Morally? It's a minefield.
I've covered enough toxic tort cases to know this much: the gap between what science knows and what courts can prove is a canyon. And we keep throwing bodies into it.
The Case That Changed Everything
The lawsuit that made it to the high court was filed by Edwin Hardeman, a California man who used Roundup for decades. He got non-Hodgkin lymphoma. His jury awarded $80 million—later reduced—but the core question was: can state tort law require warnings that go beyond EPA's approved label?
The Court said no. In a 6-3 opinion, Justice Roberts wrote that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts any state law imposing additional labeling requirements. The EPA had determined glyphosate is not a carcinogen. Hardeman's lawyers argued the EPA was wrong. Tough luck, said the Court.
“The EPA's judgment is the final word on label adequacy. States cannot second-guess it through tort litigation.” — Justice John Roberts
This isn't just about one man. It's about 165,000 pending cases. It's about the families who have been waiting years for a day in court that now may never come.
The Science Wrangle
Let's be clear: the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2015. The EPA, in 2017 and again in 2020, said it's “not likely to be carcinogenic.” The European Chemicals Agency? Also says no.
So who's right? I don't know. And that's the problem.
We have a regulatory system designed to protect public health, but it's also captured by the very industries it regulates. The EPA's glyphosate assessment was based on studies submitted by—wait for it—Monsanto. Independent research? Mostly excluded. When scientists at the University of Washington re-analyzed the data, they found a 41% increased risk of non-Hodgkin lymphoma among high-exposure farmers.
The Court didn't wade into that mess. It just said: the EPA's label is final. Suck it up.
What This Means for the Little Guy
If you're a farmer in Iowa who's been spraying Roundup for twenty years and you get cancer, your lawyer just lost a major weapon. You can't argue that the label should have said “may cause cancer” because the EPA already said no. Your only recourse is to prove Bayer knew something the EPA didn't—a nearly impossible standard given the confidentiality of industry data.
Think about that: the company that makes the product gets to hide behind a federal approval that it helped shape. The burden shifts from the corporation to the dying human.
This decision doesn't just affect Roundup. It sets precedent for every pesticide, every chemical, every product that passes EPA muster. Preemption becomes a shield. Accountability takes a hit.
Bayer's Pyrrhic Victory
Bayer shareholders cheered. The stock jumped 4% on the news. But this win comes at a cost.
Since acquiring Monsanto in 2018, Bayer has lost billions in settlement payouts and legal fees. They already set aside $16 billion to settle existing claims. The Supreme Court win doesn't erase that—it stops future claims from piling up. But it also ensures that the company will face relentless public scrutiny. No one trusts a corporation that fought to keep a cancer warning off a product used by millions.
And here's the irony: Bayer is now pushing a new weedkiller that doesn't contain glyphosate. Coming soon to a farm near you.
The Bigger Picture: Regulation by Litigation
For decades, tort law has served as a backstop for regulatory failure. When agencies lag or get captured, lawsuits force change. The tobacco settlements, the asbestos litigation—none of those would have happened if courts had deferred to federal agencies.
The Supreme Court just closed that door. From now on, if the EPA says something is safe, you can't argue otherwise in court. That's a win for regulatory efficiency. It's a loss for human rights.
We need better regulation, not less litigation. But that's a pipe dream in an era of budget cuts and anti-science rhetoric. The EPA is underfunded and overworked. Its pesticide office has lost a third of its staff since 2000. Yet we expect it to be the sole arbiter of safety for 10,000 chemicals.
Good luck.
What Comes Next
The fight isn't over. Activists are already pushing for state-level labeling laws that sidestep FIFRA's preemption. The California legislature has a bill in the works. Expect a patchwork of state rules that Bayer will challenge one by one.
And there's always Congress. The FIFRA preemption clause could be amended. But in this political climate? Don't hold your breath.
For the 165,000 plaintiffs still waiting: this stings. For the families who watched loved ones die after years of Roundup use: this is a betrayal. For the rest of us: it's a reminder that justice in America depends on which court you stand in and which lobbyist wrote the law.
Edwin Hardeman died last year. He never got his $80 million. The Supreme Court gave him a legacy: a legal principle that will shield corporations from consequences. That's not justice. That's a loophole with a gavel.
